New hope for tough pancreatic cancer cases after first treatment fails
Disease control
Completed
This study tested whether adding a new oral drug called onvansertib to a standard chemotherapy combination could help control metastatic pancreatic cancer after the first treatment stopped working. It involved 41 adults whose cancer had spread and who had already tried one prior …
Phase: PHASE2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC